Empatica

Medical wearables and AI that empower thousands of patients, clinicians and researchers with real-time human insight.

[Empatica @empatica]

Our new CE-certified Parkinson’s monitoring solution is here: EmbraceMini, a companion app & the Care Portal, powered by PKG algorithms for continuous, real-world insights and more personalized care. https://t.co/a68UmdjM8e
#ParkinsonsDisease #WearableTech #MovementDisorders

[Empatica @empatica]

We’re excited to join the Digital Breakthrough for Pharma Summit at @bmsnews, organized by @PanAgoraPharma. Our CEO Matteo Lai will discuss how to turn digital measures into regulatory-ready evidence. #DHTs

[Empatica @empatica]

The Empatica team is heading to the World Parkinson Congress in Phoenix. Looking forward to conversations that bring together researchers, clinicians, caregivers, and people living with #Parkinsons, because meaningful progress starts by listening. #WPC2026 #ParkinsonsDisease

[Empatica @empatica]

@sir4K_zen @DatalandMuseum Thank you, we can't wait for the grand opening!

[Empatica @empatica]

We are excited to announce that @DatalandMuseum opens June 20 at The Grand LA in DTLA! We're proud to help power the technologies behind this groundbreaking museum, connecting art, architecture, and the audience within a building that dreams and remembers.

Machine Dreams: Rainforest, #DATALAND’s inaugural exhibition, is an omni-sensory experience that uses data to deepen the connection between audience, machine intelligence, and the natural world.

We created a custom consumer version of EmbracePlus, our FDA-cleared wearable medical device, with adapted software and algorithms that enable real-time data streaming throughout the experience. The installation evolves in response to the audience’s collective emotional state, creating a living dialogue between people and art.

[Empatica @empatica]

Join Empatica’s Chase Babcock and Prof. Francesca Morgante to explore how continuous monitoring, wearable technology, and digital biomarkers are helping improve insights into #Parkinsons symptoms and ‘OFF’ periods beyond the clinic.
🔗Register: https://t.co/HGL9HBA65e

[Empatica @empatica]

Does wearable monitoring add burden or streamline care? Prof. K. Ray Chaudhuri shared how objective data can reduce uncertainty and improve decisions. A PKG cost-effectiveness study shows fewer hospital visits and ~£14K savings per patient.
🎥https://t.co/KjyF6NUq9U
#Parkinsons

[Empatica @empatica]

We’re recruiting participants for a usability study on a new medical wearable and companion mobile app designed to support Parkinson’s monitoring.

🎁 Thank you gift
Participants will receive a $200 gift card for their time.

Learn more and apply https://t.co/6EuDPrQztQ

#Wearables #WearableTech #WearableTechnology

[Empatica @empatica]

New @GreenJournal study shows how #SUDEP awareness shapes parental grief: lack of knowledge fuels guilt, while awareness can help families process loss. We’ll be joined by two of the study’s authors to discuss why breaking the silence matters.
Register ➡️https://t.co/ZhtAHwvcKe
#SUDEPAwareness #EpilepsyAwareness

[Empatica @empatica]

As #ParkinsonsAwarenessMonth ends, the work continues. Daily symptoms often happen outside the clinic. Continuous monitoring can bring clarity between visits, helping inform better treatment and more personalized care. #Parkinsons #DigitalHealth

[Empatica @empatica]

Hearing loss is linked to cognitive decline & dementia. New research with @EriksholmRC published in @Sciencedirect shows the EmbracePlus can predict listening effort using biomarkers, unlocking real-world endpoints in #aging & #neuroresearch https://t.co/mZkjeNrA0S

[Empatica @empatica]

#RCTs are essential for evaluating new treatments, yet ~20–25% are discontinued early (@JClinEpi). We surveyed researchers using EmbracePlus 👉92% achieved ≥75% completion. Better participant experience and onboarding can support sustained engagement.
🔗 https://t.co/01LxO3VhAt

[Empatica @empatica]

Join our webinar on SUDEP (Sudden Unexpected Death in Epilepsy) to explore new research published in @GreenJournal on awareness, grief, and communication. Hear from leading experts and our Chief Scientist, @RosalindPicard.
👉https://t.co/yMEKH1lOWA
#Epilepsy #SUDEP #Neurology

[Empatica @empatica]

As #ParkinsonsAwarenessMonth continues, a key gap remains: care decisions rely on snapshots, while symptoms fluctuate at home. A 12-month PKG analysis published in @MDPIOpenAccess shows it can better inform treatment and reduce caregiver burden➡️ https://t.co/l4ntJjfGU0 #PD

[Empatica @empatica]

Participant compliance has long been seen as a risk, which may be driving larger, costlier trials. We surveyed 84 clients, and 90% reported ≥80% compliance. 🔗Read more: https://t.co/E7LvaYVpTM
#DigitalHealth #WearableTech

[Empatica @empatica]

We’ll be at the American Academy of Neurology Annual Meeting in Chicago! Visit us at booth #4432 to see EpiMonitor and our CE-certified Parkinson’s solution in action, and learn how we’re advancing neurology care and research with continuous, real-world data. @AANmember #AAN2026

[Empatica @empatica]

Optimizing #Parkinsons care means linking objective data to real outcomes. PKG-guided treatment improved quality of life in patients with poorer baseline scores and reduced caregiver burden in a 12-month study.
🎥 Watch the full webinar: https://t.co/8rlGcrK0Ii
#DigitalHealth

[Empatica @empatica]

📣 EpiMonitor is now available in Canada, Australia & New Zealand! Following key regulatory milestones, including ARTG listing and a Health Canada license, we’re expanding access to our medical-grade epilepsy monitoring worldwide. 👉 https://t.co/kWgVHbLJwI #SeizureMonitoring

[Empatica @empatica]

New validation shows PKG algorithms deliver consistent results on EmbracePlus & EmbraceMini vs the PKG Watch. Strong agreement across bradykinesia, dyskinesia & tremor supports reliable Parkinson’s monitoring in research & real-world use. 📄https://t.co/usYbc5jBXz